ADA2019: find the two Adocia abstracts including the “BioChaperone® Glucagon Exenatide” Poster online

Last June 9th and 10th, Adocia presented two abstracts during the 79th Scientific Sessions organized by the American Diabetes Association® this year at the Moscone Center in San Francisco (USA)

 

  • Oral  Presentation #150-OR: Biochaperone Pramlintide Insulin (BCPramIns), A New Co-formulation Of Pramlintide (pram) And Human Insulin (ins), Improves Post-prandial Blood Glucose (BG) Versus Both Separate Injections Of Pram+Ins And Insulin Lispro (lis) in Subjects With T1D, Auteur : Dr. Grégory Meiffren

 

  • Poster #2008-P: BioChaperone Glucagon Exenatide (BC Glu Exe), a Stable Combination of Glucagon (Glu) and Exenatide (Exe) Achieved Larger Body Weight (BW) Loss than Exe Alone in DIO Mice, Auteur : Dr. Martin Gaudier

Retrouvez le Poster sur ce lien : Poster Adocia ADA-2019 BC Glucagon GLP-1

https://ada2019.org/